Phosphorylation of vasodilator-stimulated phosphoprotein (VASP) dampens hepatic ischemia-reperfusion injury

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Köhler, David ^a   Birk, Philipp ^a   König, Klemens ^b   Straub, Andreas ^a   Eldh, Therese ^a   Morote Garcia, Julio C ^a   Rosenberger, Peter ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; LACTATE DEHYDROGENASE; PROSTAGLANDIN E1; SERINE; SMALL INTERFERING RNA; VASODILATOR STIMULATED PHOSPHOPROTEIN; ACTIN BINDING PROTEIN; CELL ADHESION MOLECULE; PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER INJURY; LIVER ISCHEMIA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; THROMBOCYTE; WILD TYPE; ANIMAL; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; VASCULARIZATION; WESTERN BLOTTING;

ALPROSTADIL; ANIMALS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; REPERFUSION INJURY;

EID: 84055172787     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029494     Document Type: Article

References (36)

1. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA, (2008) Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 147: 153-159.
2. Carden DL, Granger DN, (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190: 255-266.
3. Vollmar B, Richter S, Menger MD, (1997) Liver ischemia/reperfusion induces an increase of microvascular leukocyte flux, but not heterogeneity of leukocyte trafficking. Liver 17: 93-98.
4. Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D, (1995) Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am J Physiol 269: G297-304.
5. Walsh KB, Toledo AH, Rivera-Chavez FA, Lopez-Neblina F, Toledo-Pereyra LH, (2009) Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant 7: 78-93.
6. Zarbock A, Singbartl K, Ley K, (2006) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116: 3211-3219.
7. Xu Y, Huo Y, Toufektsian MC, Ramos SI, Ma Y, et al. (2006) Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 290: H692-699.
8. Kornerup KN, Salmon GP, Pitchford SC, Liu WL, Page CP, (2010) Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration. J Appl Physiol 109: 758-767.
9. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, et al. (1999) Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 106: 391-399.
10. Kohler D, Straub A, Weissmuller T, Faigle M, Bender S, et al. (2011) Phosphorylation of Vasodilator-Stimulated Phosphoprotein Prevents Platelet-Neutrophil Complex Formation and Dampens Myocardial Ischemia-Reperfusion Injury. Circulation.
11. Benz PM, Blume C, Seifert S, Wilhelm S, Waschke J, et al. (2009) Differential VASP phosphorylation controls remodeling of the actin cytoskeleton. J Cell Sci.
12. Ibarra-Alvarado C, Galle J, Melichar VO, Mameghani A, Schmidt HH, (2002) Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling. Mol Pharmacol 61: 312-319.
13. Sugawara Y, Kubota K, Ogura T, Esumi H, Inoue K, et al. (1998) Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J Hepatol 29: 969-976.
14. Hafez T, Moussa M, Nesim I, Baligh N, Davidson B, et al. (2007) The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury. J Surg Res 138: 88-99.
15. Gerwig T, Meissner H, Bilzer M, Kiemer AK, Arnholdt H, et al. (2003) Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol 39: 341-348.
16. Kulhanek-Heinze S, Gerbes AL, Gerwig T, Vollmar AM, Kiemer AK, (2004) Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers. J Hepatol 41: 414-420.
17. Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, et al. (1999) Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci U S A 96: 8120-8125.
18. Hart ML, Much C, Kohler D, Schittenhelm J, Gorzolla IC, et al. (2008) Use of a hanging-weight system for liver ischemic preconditioning in mice. Am J Physiol Gastrointest Liver Physiol 294: G1431-1440.
19. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, et al. (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101: 593-600.
20. Henes J, Schmit MA, Morote-Garcia JC, Mirakaj V, Kohler D, et al. (2009) Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J 23: 4244-4255.
21. Köhler D, Straub A, Weissmüller T, Faigle M, Bender S, et al. (2011) Phosphorylation of vasodilator-stimulated phosphoprotein (VASP) prevents platelet-neutrophil complex formation and dampens myocardial ischemia-reperfusion injury. Circulation in print.
22. Straub A, Krajewski S, Hohmann JD, Westein E, Jia F, et al. (2011) Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arterioscler Thromb Vasc Biol 31: 1607-1616.
23. Chen H, Levine YC, Golan DE, Michel T, Lin AJ, (2008) Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium. J Biol Chem 283: 4439-4447.
24. Weissmuller T, Campbell EL, Rosenberger P, Scully M, Beck PL, et al. (2008) PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest 118: 3682-3692.
25. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, et al. (2007) CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116: 1784-1794.
26. Cywes R, Harvey PR, Packham MA, Cameron R, Strasberg SM, (1996) The influence of prostaglandin E1 on platelet adherence and injury in preserved rat liver allografts. Liver Transpl Surg 2: 23-36.
27. Khandoga A, Biberthaler P, Enders G, Teupser D, Axmann S, et al. (2002) P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo. Shock 18: 529-535.
28. Khandoga A, Biberthaler P, Enders G, Axmann S, Hutter J, et al. (2002) Platelet adhesion mediated by fibrinogen-intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation 74: 681-688.
29. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, et al. (1999) P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 29: 1494-1502.
30. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, et al. (1993) Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 17: 915-923.
31. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP, (2002) Role of vasodilator-stimulated phosphoprotein in protein kinase A-induced changes in endothelial junctional permeability. Faseb J.
32. Hossain MA, Hamamoto I, Wakabayashi H, Goda F, Kobayashi S, et al. (1999) Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy. Br J Surg 86: 776-783.
33. Natori S, Fujii Y, Kurosawa H, Nakano A, Shimada H, (1997) Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 64: 1514-1520.
34. Bilzer M, Witthaut R, Paumgartner G, Gerbes AL, (1994) Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology 106: 143-151.
35. Kiemer AK, Gerbes AL, Bilzer M, Vollmar AM, (2002) The atrial natriuretic peptide and cGMP: novel activators of the heat shock response in rat livers. Hepatology 35: 88-94.
36. Kobayashi K, Oshima K, Muraoka M, Akao T, Totsuka O, et al. (2007) Effect of atrial natriuretic peptide on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model. World J Gastroenterol 13: 3487-3492.